Hepatitis C virus (HCV)-RNA in sera of patients with viral hepatitis C is supposed to be included, at least partially, into HCV particles. We found that the density of HCV-RNA-carrying material was variable, as determined by sucrose gradient density centrifugation (1.03-1.20g/cm3). In some of the se
Density heterogeneities of hepatitis C virus in human sera due to the binding of β-lipoproteins and immunoglobulins
✍ Scribed by R. Thomssen; S. Bonk; A. Thiele
- Publisher
- Springer-Verlag
- Year
- 1993
- Tongue
- English
- Weight
- 387 KB
- Volume
- 182
- Category
- Article
- ISSN
- 0300-8584
No coin nor oath required. For personal study only.
✦ Synopsis
Heterogeneities in the density of hepatitis C virus RNA-carrying material (HCV-RNA-CM) found in human sera (1.03-1.20g/cm 3) are attributed to the binding of low-density lipoproteins and/or of IgG. In some sera HCV-RNA-CM seems to be nearly totally bound to 13-1ipoproteins and cannot be precipitated by anti-IgG (7); in others more than 95% of HCV-RNA-CM is bound to IgG and cannot be precipitated by anti-13-1ipoprotein. Furthermore, there are sera from which HCV-RNA-CM can be completely be precipitated by either anti-13lipoprotein or anti-IgG (7), pointing to a binding of the two serum proteins to the same HCV-RNA-CM. There are other sera from which HCV-RNA-CM can be partially precipitated by the one or the other antiserum, leaving behind fractions, which are bound to 13-1ipoprotein or to IgG. HCV-RNA-CM cannot be precipitated from some sera either by anti-13-1ipoprotein or by anti-IgG (7).
📜 SIMILAR VOLUMES
## Abstract HCV recovered from low density fractions of infected blood is associated with lipid and host apo‐lipoproteins in lipo‐viro‐particles (LVP). It has been proposed that these particles are capable of binding and entering hepatocytes by viral glycoprotein independent mechanisms utilizing up
Serum samples (1,428) from 1,149 patients with chronic liver diseases and polfiransfused subjects were tested for antibody to hepatitis C virus by first-generation enzyme immunoassays. Antibody to hepatitis C virus was detected in 87% of patients with transfusion-related chronic non-A, non-B hepatit
Two genomic regions of hepatitis C virus (HCV), the interferon sensitivity-determining region (ISDR) of the non-structural 5A gene (NS5A) and the protein kinase-RNA activated (PKR)-eukariotic transcription factor (eIF2-alpha) phosphorylation homology domain (PePHD) of the structural E2 gene, interac
## Abstract Sera obtained from 381 patients with chronic liver disease from four cities within the USSR were studied for HBV, HDV, and HCV markers of infection. Anti‐HCV activity was detected in 41.2% of non‐A, non‐B cases. The etiological distribution of chronic hepatitis in Moscow and Dushanbe wa